Table 2.
Table | Type of Study | Number | Levels of Evidence (LoE) | |||||
---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | ? | |||
3a | Narrative reviews/expert opinions | 41 | / | / | / | / | 41 | / |
3b | Retrospective outcome studies | 16 | / | / | 16 | / | / | / |
3c | Surveys | 5 | / | 5 | / | / | / | / |
4 | Premedication/sedation and induction drugs | 59 | 33 | 3 | 2 | 14 | / | 7 |
5a | Maintenance with inhalant agents | 27 | 9 | 4 | / | 13 | 1 | / |
5b | Maintenance with TIVA | 55 | 19 | 4 | / | 32 | / | / |
5c | TIVA vs. inhalants | 3 | 2 | 1 | / | / | / | / |
6 | Maintenance with PIVA | 56 | 43 | 5 | 2 | 4 | 2 | / |
7a | Loco-regional during maintenance | 9 | 6 | / | 2 | 1 | / | / |
7b | NMBAs during maintenance | 10 | 2 | / | / | 6 | 1 | 1 |
7c | Other drugs used during maintenance | 8 | 4 | 1 | 2 | 1 | / | / |
8 | Drugs before/during recovery | 18 | 18 | / | / | / | / | / |
9 | Recovery systems | 18 | 5 | / | 2 | 9 | 2 | / |
10 | Respiratory system in recovery | 21 | 15 | 3 | / | 3 | / | / |
11 | Other factors | 41 | 8 | 8 | 6 | 15 | 4 | / |
12 | Case series/reports | 51 | / | / | / | 12 | 39 | / |
13 | Systems to score recoveries | 6 | 3 | 2 | 1 | / | / | / |
Total (5 April 2021) | 444 | 167 | 36 | 33 | 110 | 90 | 8 |
Abbreviations in alphabetical order: NMBAs, neuromuscular blocking agents; PIVA, partial intravenous anaesthesia, TIVA, total intravenous anaesthesia. ?: publications in which the study was not able to be classified according to levels of evidence (LoE) based on the available abstract.